CloudMD Increases Doctor Onboarding Amid Growing Coronavirus (COVID-19) Concerns

VANCOUVER, British Columbia, March 09, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (CSE:DOC)(OTCQB:PHGRF)(Frankfurt: 6PH)(the “Company” or “CloudMD”), a Company focused on revolutionizing the delivery of healthcare, announces it has increased doctor onboarding efforts for CloudMD, the Company’s direct-to-consumer telemedicine app, to handle the expected increased demand amidst the growing coronavirus spread.

Recently, officials from both the Centers for Disease Control and the World Health Organization urged hospitals and clinics to expand their use of telehealth services. Virtual care options such as video visits can be an effective way to evaluate and treat illnesses from the comfort of one’s home, while minimizing exposure to other potentially contagious viruses.

“As demand for our services is expected to rise amidst the current Coronavirus outbreak, we are increasing our physician recruitment to manage the increased demand.” said Dr. Essam Hamza, CEO of CloudMD. “It’s better to triage patients remotely, sending only complex cases to over-stretched hospitals, allowing for a more efficient use of healthcare resources and ultimately higher quality of care for the patient population.”


The Company’s CEO has recently been interviewed by multiple news sources as the public health concerns around the Coronavirus grows. See links below:


In addition, the Company would like to announce, pursuant to its previously announced brokered financing with Gravitas Securities dated March 2, that the order book is through the base offering of $3 million based on significant interest, and the book will be closing Wednesday, March 11 at 4:00 PM EST.

To learn more about CloudMD’s telemedicine services, visit The CloudMD app is now available for download on the Apple Store and Google Play.                                                                               

About CloudMD Software & Services

CloudMD Software & Services Inc. (CSE:DOC)(OTCQB:PHGRF)(Frankfurt: 6PH) is digitizing the delivery of healthcare by providing patients access to all points of their care from their phone, tablet or desktop computer. The company offers SAAS based health technology solutions to medical clinics across Canada and has developed proprietary technology that delivers quality healthcare through the combination of connected primary care clinics, telemedicine, and artificial intelligence (AI). CloudMD currently has a combined ecosystem of 315 clinics, over 3000 licensed practitioners and almost 3 million registered patients.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Please See Disclaimer


1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector.

2) The Article was issued on behalf of a third party, CloudMD Software & Services Inc. Market Jar Media Inc. expects to receive the following amounts from Native Ads Inc. in the amount of one hundred eight thousand and eight hundred CAD Dollars for 76 campaign days (54 business days).

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.